A recent small-sample survey published online March 22 in Genetics in Medicine found direct-to-consumer DNA tests may produce false-positives in 40 percent of variants when subjected to clinical confirmation testing.

Pressure from lower-priced healthcare options has already been hitting hospitals’ bottom lines. If Walmart’s early talks to acquire Humana come to fruition, that pressure would only intensify, according to the Wall Street Journal.

A researcher at Vanderbilt University’s Owen Graduate School of Management has linked over 2,100 patient deaths to hospital data breaches and lack of cybersecurity.

Monitoring medication adherence may take a step forward with smartphone apps that require patients to snap 'selfies' before and after they take medication.

A woman going through pregnancy shouldn’t actively avoid going to the doctor—but Allison Matthews, considered at low risk for certain complications like preeclampsia during her first pregnancy, didn’t see much benefit in shuffling to and from physicians’ offices.

Royal Philips and Innovative Imaging Technologies (IIT) have announced a partnership to integrate Philips’ Lumify portable ultrasound system and IIT’s Reacts collaborative platform for a comprehensive tele-ultrasound solution.

The new CEO of Novartis, Vas Narasimhan, is pushing the drug company to embrace artificial intelligence, telemedicine and automation as keys to its future.

A device worn like a visor can detect emergent large-vessel occlusion in patients with a suspected stroke with 92 percent accuracy, according to a study published March 6 in the Journal of Neurointerventional Surgery.